#COVID-19: ARVs Cost Could Go Up- UNAIDS Warns

THE COVID-19 could affect the availability, cost and distribution of antiretroviral (ARVs) medicines  in low- and middle-income countries around the world, a new UNAIDS study has revealed. HealthTimes Reporter According the study, the impact on production and logistics caused by COVID-19 could have a significant effect on antiretroviral therapy supply worldwide, but steps taken now could lessen the damage done. The UNAIDS survey discovered that the lockdowns and border closures imposed to stop COVID-19 are impacting both the production of medicines and their distribution, potentially leading to increases in their…

Share
Read More